Contrarian Bull Note Boosts Dialysis Stock

DVA is fresh off a post-earnings bull gap from Friday

Jake Scott

Deputy Editor

Aug 7, 2023 at 10:14 AM

The shares of dialysis machine maker DaVita Inc (NYSE:DVA) are 6.6% higher to trade at $115.36 this morning, and earlier hit an 18-month high of $116.52. The breakout comes after UBS upgraded DVA to "buy" from "neutral" and hiked its price target to $142 from $100, telling clients in a note that it sees "tailwinds that support our Street-high earnings estimates and contrarian 'buy' rating."

Thanks to a post-earnings bull gap of 7.1% on Friday and today's gains, DaVita stock is now up 55% year-to-date and 35% year-over-year. Prior to the two-session breakout, the shares had support in place at their ascending 50-day moving average. This trendline caught pullbacks in the last two months and hasn't been breached on a closing basis since late March.

This is the stock's first "buy" rating among the brokerage bunch; coming into today, all seven brokerages rated DaVita stock a "hold" or "sell." Plus, the 12-month average target price of $112 remains a roughly 1.8% discount to the equity's current perch.

Follow @Schaeffers

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.